As a standard tumor marker, CD133 is overexpressed in many tumors, including colon cancer, liver cancer, and ovarian cancer.[164] CD133 has been targeted by a peptide CP conjugated to an organic D‐A‐D dye IRT. Here, PROM1 is linked to malignant colon neoplasm.